Axtria PMSA Webinar Series

Axtria delivered its second session on ‘Sales Force Sizing & Portfolio Optimization’ during PMSA Webinar Series 2015 on 30th September

In the second PMSA Webinar Series 2015 session, which is a one-of-its-kind platform for discussion and collaboration on best practices in sales operations, Axtria’s David Wood (PhD) and Rajnish Kumar delivered another engaging session on ‘Sales Force Sizing & Portfolio Optimization’. The webinar discussed the various approaches to determining the best sales force size (SFS) and covered several key areas such as:

  •          Classic approaches to Sales Force Sizing
  •          Advantages and limitations
  •          Illustrative case studies

    This informative session, attended by professionals, received high scores on its insightfulness & applicability as well as speaker’s ability to engage the audience. The session attracted several reviews such as - ‘a great overview of sizing exercises’, ‘a very good primer for people without direct experience in sizing work’ , and more. A much – appreciated aspect of the presentation was its simplicity in delivering some of the more complex concepts of modelling and scenario analysis. To quote one of the participants – “..I like the way the presentation started with the basic models and built layers of complexity on top of the basic approach’.

    In case you missed the webinar, you can listen to the recording here. In case you have any questions please feel free to reach out to

Tags: News Publishing, Blog, Press Release

Axtria Connect

Axtria combines industry knowledge, analytics and technology to help clients make better data-driven decisions. Its data analytics and cloud-based platforms support sales, marketing, and risk management decisions. It serves clients with a high-touch on-site and onshore presence, leveraged by a global delivery platform that reduces the total cost of ownership with efficient execution, innovation, and virtualization. Axtria works with more than 30 clients, including five of the Fortune 50, and eight of the top 10 global life sciences companies.

Subscribe to Email Updates

Recent Posts